Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_assertion type Assertion NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_head.
- NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_assertion description "[Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_provenance.
- NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_assertion evidence source_evidence_literature NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_provenance.
- NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_assertion SIO_000772 24519943 NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_provenance.
- NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_assertion wasDerivedFrom befree-2016 NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_provenance.
- NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_assertion wasGeneratedBy ECO_0000203 NP1154450.RAXC1p_LXJWlz9jgIbGHp848aKqNPvTntJ6sUbwD0dMlg130_provenance.